B R Winkelmann

Summary

Country: Germany

Publications

  1. ncbi Genomics and large scale phenotypic databases
    B R Winkelmann
    Heart Centre Ludwigshafen, Cardiovascular Molecular Genetics Laboratory, Bremser Str 79, Ludwigshafen, D 67063, Germany
    Pharmacogenomics 2:3-5. 2001
  2. ncbi Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease
    B R Winkelmann
    Medical Clinic B, Ludwigshafen Heart Centre, Cardiovascular Molecular Genetics Laboratory, Bremser Str 79, Ludwigshafen D 67063, Germany
    Pharmacogenomics 2:S1-73. 2001
  3. ncbi Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease
    B R Winkelmann
    Kooperationseinheit Pharmakogenomik Angewandte Genomforschung, Universitatsklinikum Heidelberg, Germany
    Curr Med Res Opin 17:132-41. 2001
  4. ncbi Pharmacogenomics--10 years of progress: a cardiovascular perspective
    Bernhard R Winkelmann
    Johann Wolfgang Goethe University, Frankfurt, ClinPhenomics GmbH and Kardiologie Frankfurt Sachsenhausen, Frankfurt, Germany
    Pharmacogenomics 11:613-6. 2010
  5. ncbi Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk
    J Bach
    Institute of Hemostaseology and Transfusion Medicine, Academic City Hospital, Ludwigshafen, Germany
    J Thromb Haemost 6:291-6. 2008
  6. ncbi Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease
    R Zahn
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Blood Coagul Fibrinolysis 13:81-7. 2002

Collaborators

Detail Information

Publications6

  1. ncbi Genomics and large scale phenotypic databases
    B R Winkelmann
    Heart Centre Ludwigshafen, Cardiovascular Molecular Genetics Laboratory, Bremser Str 79, Ludwigshafen, D 67063, Germany
    Pharmacogenomics 2:3-5. 2001
    ....
  2. ncbi Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease
    B R Winkelmann
    Medical Clinic B, Ludwigshafen Heart Centre, Cardiovascular Molecular Genetics Laboratory, Bremser Str 79, Ludwigshafen D 67063, Germany
    Pharmacogenomics 2:S1-73. 2001
    ..Long-term follow-up on clinical events will allow us to study the prognostic importance of common genetic variants (polymorphisms) and plasma biomarkers...
  3. ncbi Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease
    B R Winkelmann
    Kooperationseinheit Pharmakogenomik Angewandte Genomforschung, Universitatsklinikum Heidelberg, Germany
    Curr Med Res Opin 17:132-41. 2001
    ..However, the role of hyperinsulinemia, a marker of insulin resistance, as a risk factor for atherosclerosis remains to be clarified...
  4. ncbi Pharmacogenomics--10 years of progress: a cardiovascular perspective
    Bernhard R Winkelmann
    Johann Wolfgang Goethe University, Frankfurt, ClinPhenomics GmbH and Kardiologie Frankfurt Sachsenhausen, Frankfurt, Germany
    Pharmacogenomics 11:613-6. 2010
    ....
  5. ncbi Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk
    J Bach
    Institute of Hemostaseology and Transfusion Medicine, Academic City Hospital, Ludwigshafen, Germany
    J Thromb Haemost 6:291-6. 2008
    ..Whether factor XII (FXII) activity, its 46C>T polymorphism and activated FXII (FXIIa) are associated with coronary heart disease (CHD) remains to be determined...
  6. ncbi Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease
    R Zahn
    Department of Cardiology, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
    Blood Coagul Fibrinolysis 13:81-7. 2002
    ..This association was significant only for men. It may indicate a contribution of the APC resistance to the development of CAD, which has to be proven by the follow-up...